SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that…
Biotechnology
US, Stamford [HQ]
SWTX/Financials
Segments · Problems · Premarket · Compliance
Segment Analysis
Segments · Problems · Premarket · ComplianceSegment Analysis
Revenue · By Business Segment
These hierarchically ordered segment trees are sourced from the most recent 10-K filings, directly from the SEC.
Not available for SWTX
Revenue · By Area
This map and table comes from the most recent 10-K filings, directly from the SEC.
Not available for SWTX